Aerovate Therapeutics Inc... (AVTE)

AI Score

Unlock

2.75

0.01 (0.36%)

At close: Apr 24, 2025, 3:59 PM

2.70

-1.64%

After-hours: Apr 24, 2025, 06:21 PM EDT

Aerovate Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Net Income	-69.63M	-84.61M	-87.94M	-82.19M	-75.52M	-70.13M	-64.16M	-57.12M	-51.51M	-44.71M	-37.31M	-31.09M	-22.96M	-18.41M	-14.53M	-10.96M	-9.61M	-5.95M	-3.64M	-1.44M
Depreciation & Amortization	-1.63M	-1.61M	109K	103K	96K	88K	83K	78K	68K	56K	39K	24K	15K	8K	5K	3K	1K	n/a	n/a	n/a
Stock-Based Compensation	11.31M	13.32M	14.55M	13.72M	11.91M	10.38M	8.65M	6.84M	5.48M	4.6M	3.95M	3.04M	2.04M	1.21M	389K	74K	58K	34K	13K	7K
Other Working Capital	-4.62M	5.8M	3.23M	3.93M	9.96M	6.39M	3.27M	5.03M	6.39M	941K	-1.74M	-2.74M	-7.12M	-1.67M	503K	-924K	937K	187K	299K	77K
Other Non-Cash Items	-1.72M	2.45M	4.57M	4.63M	1.29M	-2.7M	-2.19M	-1.61M	-910K	-308K	-256K	332K	-435K	-444K	-140K	-90K	726K	719K	655K	78K
Deferred Income Tax	n/a	-4.35M	-4.35M	-4.35M	-4.35M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-6.1M	3.27M	1.96M	2.48M	9.8M	5.52M	6.66M	6.93M	7.75M	3.01M	-818K	-1.31M	-6.51M	-5K	974K	-213K	974K	217K	428K	168K
Operating Cash Flow	-71.2M	-74.95M	-74.52M	-69.03M	-56.78M	-56.84M	-50.95M	-44.88M	-39.12M	-37.35M	-34.16M	-29.29M	-27.4M	-17.19M	-13.1M	-10.45M	-7.86M	-4.97M	-2.54M	-1.18M
Capital Expenditures	n/a	-64K	-96K	-126K	-142K	-82K	-83K	-183K	-195K	-276K	-299K	-169K	-181K	-96K	-40K	-40K	n/a	n/a	n/a	n/a
Cash Acquisitions	n/a	-5.71K	7.39K	3.37K	-12.02K	-20.8K	-38.57K	-42.88K	-27.49K	-13K	-8.32K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	-19.68M	-47.47M	-90.39M	-123.12M	-123.98M	-146.45M	-124.18M	-130.34M	-147.62M	-210.62M	-185.04M	-146.14M	-113.25M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	62.58M	96.08M	109.83M	128.58M	136M	167.25M	162.75M	173.22M	154.74M	89.99M	59.74M	12.52M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	21.96M	8.84M	8.83M	8.83M	12.02K	20.8K	38.57K	42.88K	-20.34M	-133.61M	-133.62M	-133.62M	-113.25M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	56.03M	48.55M	19.35M	5.33M	11.88M	20.71M	38.49M	42.7M	6.93M	-120.9M	-125.6M	-133.79M	-113.43M	-96K	-40K	-40K	n/a	n/a	n/a	n/a
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	25.12M	25.34M	25.33M	46.24M	46M	45.89M	45.91M	619K	396K	39K	128.31M	127.3M	127.19M	127.19M	1.39M	2.4M	2.5M	2.5M	n/a	n/a
Financial Cash Flow	25.43M	25.34M	25.33M	46.24M	46M	45.89M	45.91M	619K	396K	-211K	128.06M	182.57M	190.46M	190.71M	71.31M	16.8M	8.92M	8.92M	n/a	n/a
Net Cash Flow	10.26M	-1.06M	-29.83M	-17.45M	1.09M	9.76M	33.44M	-1.57M	-31.8M	-158.46M	-31.69M	19.5M	49.62M	173.42M	58.18M	6.31M	1.06M	3.94M	-2.54M	-1.18M
Free Cash Flow	-71.2M	-75.01M	-74.61M	-69.15M	-56.92M	-56.92M	-51.03M	-45.07M	-39.32M	-37.63M	-34.45M	-29.45M	-27.58M	-17.29M	-13.14M	-10.49M	-7.86M	-4.97M	-2.54M	-1.18M